Grail (GRAL) closed at $121.44 on November 6, 2026, up 1.9% from the previous close, on volume of 738,781 shares (30-day average 1,040,700).
Data as of November 6, 2026.
| # | Date | Strategy | Legs | Contracts | Position |
|---|---|---|---|---|---|
| 1 | Oct 8, 2026 | Call Spread | 16-Oct-2680 : 100 C | 1,000 | |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | ||||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 6, 2026. See the 10 largest for 30, 60 and 90 days
GRAIL: Buy Rating Maintained with $150 Price Target Unchanged Amid Long-Term Growth Potential
TipRanks (Thu, 5-Nov 5:46 PM ET)
Piper Sandler Remains a Hold on GRAIL Inc (GRAL)
TipRanks (Thu, 5-Nov 9:28 AM ET)
Analysts Are Bullish on Top NA Stocks: Circle Internet Group, Inc. Class A (CRCL), GRAIL Inc (GRAL)
TipRanks (Thu, 5-Nov 9:02 AM ET)
GRAIL Inc (GRAL) Receives a Hold from Goldman Sachs
TipRanks (Thu, 5-Nov 7:39 AM ET)
RBC Capital Remains a Hold on GRAIL Inc (GRAL)
TipRanks (Thu, 5-Nov 7:38 AM ET)
GRAIL, Inc. GAAP EPS of -$2.21 beats by $0.28, revenue of $37.5M misses by $6.71M
Seeking Alpha News (Wed, 4-Nov 4:08 PM ET)
GRAIL Reports Third Quarter 2026 Financial Results
PRNewswire (Wed, 4-Nov 4:02 PM ET)
GRAIL to Present at the UBS Global Healthcare Conference
PRNewswire (Tue, 27-Oct 4:02 PM ET)
GRAIL to Announce Third Quarter 2026 Financial Results
PRNewswire (Wed, 21-Oct 4:03 PM ET)
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
Grail trades on the NASDAQ stock market under the symbol GRAL.
As of November 9, 2026, GRAL stock price climbed to $131.45 with 278,968 million shares trading.
GRAL has a beta of 1.67, meaning it tends to be more sensitive to market movements. GRAL has a correlation of 0.04 to the broad based SPY ETF.
GRAL has a market cap of $5.91 billion. This is considered a Mid Cap stock.
Last quarter Grail reported $37 million in Revenue and -$2.21 earnings per share. This fell short of revenue expectation by $-7 million and missed earnings estimates by -$.13.
The top ETF exchange traded funds that GRAL belongs to (by Net Assets): VTI, IWM, XBI, VXF, IWN.
GRAL has outperformed the market in the last year with a price return of +64.2% while the SPY ETF gained +13.2%. GRAL has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +107.3% and -0.8%, respectively, while the SPY returned -2.0% and -1.2%, respectively.
GRAL support price is $114.51 and resistance is $128.37 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GRAL shares will trade within this expected range on the day.
